Stock A144510 GC CELL CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Other languages GC Cell Corporation

Equities

A144510

KR7144510005

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 29/04/2024 BST 		5-day change 1st Jan Change
38,500 KRW +0.26% Intraday chart for GC Cell Corporation +2.80% -15.38%
02-26 GC Cell and Biocentriq® Execute Process Transfer Agreement in Anticipation of the U.S. Entry of Immuncell-LC Inj CI
01-08 GC Cell's Promising AB-201 Cancer Treatment to Begin Phase 1 Trials Using Lunit AI Platform CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
GC Cell and Biocentriq® Execute Process Transfer Agreement in Anticipation of the U.S. Entry of Immuncell-LC Inj
GC Cell's Promising AB-201 Cancer Treatment to Begin Phase 1 Trials Using Lunit AI Platform
GC Cell Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
GC Cell Inks First Licensing Agreement for Immuncell-LC® With Rivaara Immune Private Limited in India
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A144510 Stock
  4. News GC Cell Corporation
  5. Other languages